MedTrace Logo

The CARRA Registry

NCT01697254 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9587

Last updated 2015-11-17

No results posted yet for this study

Summary

This CARRA Registry study will create a foundational database for rheumatic diseases of childhood using a novel informatics infrastructure developed as part of the larger clinical project. The creation of a CARRA-wide informatics infrastructure will enable efficient, observational, disease-related data capture across all CARRA sites for pediatric rheumatic diseases. The CARRA Registry study will demonstrate the feasibility of expanding to more data intensive registries for observational studies, comparative effectiveness research, pharmaceutical clinical trials and translational research.

Conditions

  • Juvenile Idiopathic Arthritis
  • Systemic Lupus Erythematosus
  • Mixed Connective Tissue Disease
  • Juvenile Ankylosing Spondylitis
  • Juvenile Dermatomyositis
  • Localized Scleroderma
  • Systemic Sclerosis
  • Vasculitis
  • Sarcoid
  • Fibromyalgia, Primary
  • Auto-inflammatory Disease
  • Idiopathic Uveitis Idiopathic

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • Arthritis Foundation

    collaborator OTHER

  • Lupus Foundation of America

    collaborator OTHER

  • Cure JM Foundation

    collaborator UNKNOWN

  • Duke University

    lead OTHER

Principal Investigators

  • Laura Schanberg, MD · Duke University

  • Norman T Illowite, MD · Children's Hospital at Montefiore

  • Christy Sandborg, MD · Lucile Salter Packard Children's Hospital/Stanford University School of Medicine

  • Carol Wallace, MD · Seattle Children's Hospital/ University of Washington School of Medicine

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01697254 on ClinicalTrials.gov